Search for: "Merck and Co," Results 61 - 80 of 1,284
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Jan 2022, 5:56 am by MaxVal
This week’s newest patent applications are from Integrated Solution for Systems Inc, Novartis, Abbott, Roche, Medtronic, Merck, Boston Scientific, Mastercard, IBM, Apple, Microsoft, and Intel. [read post]
15 Jan 2022, 8:41 pm by Patent Docs
Tom Irving, Mark Feldstein, and Joshua Goldberg of Finnegan, Henderson, Farabow, Garrett & Dunner, LLP; Jessica Marks of Unified Patents; and Nichole Valeyko of Merck & Co. will highlight important PTAB decisions from 2021, as well as impacts on PTAB practice from external sources such as the Supreme Court, Federal Circuit, and Congress, and what to watch out for in 2022. [read post]
6 Jan 2022, 9:16 pm by MaxVal
This week’s newest patent applications are from Google, Abbott, Boston Scientific, Medtronic, Merck, Roche, PayPal, Intel, Microsoft, IBM, and Apple. [read post]
5 Jan 2022, 4:33 am by Jon L. Gelman
Gelman of Wayne NJ is the author of NJ Workers’ Compensation Law (Thomson-Reuters) and co-author of the na [read post]
4 Jan 2022, 11:32 pm by MaxVal
The method includes exposing a surface of the substrate comprising a metal portion, to a metal-organic precursor, selectively depositing a metal-organic precursor on an upper surface of the metal portion, exposing the metal precursor layer to a co-reactant, and depositing the co-reactant on the metal precursor layer, wherein the co-reactant takes part in a ligand exchange with the metal precursor layer. [read post]
19 Nov 2021, 10:46 am by Rebecca Tushnet
Neurelis argued that the exemption to the anti-SLAPP law was specifically focused on overturning DuPont Merck Pharmaceutical Co. v. [read post]
31 Oct 2021, 9:20 pm by Patent Docs
Ashita Doshi of Thermo Fisher Scientific, Nichole Valeyko of Merck & Co., Ben Searle of HP Inc., and Todd Walters of Buchanan Ingersoll & Rooney PC will discuss strategies and practical tips for obtaining patent portfolios that survive post-grant attacks, including a discussion of the following topics: PTAB statistics, application drafting, claim drafting strategies, prosecution strategies, obtaining a robust portfolio, and knowing when and where to assert your... [read post]
20 Oct 2021, 4:25 pm by Holly Buckley
Co-investors joining Carlyle in the investment included Amgen Ventures, Intermountain Ventures, Merck Global Health Innovation Fund, McKesson Ventures, Northpond Ventures, Pfizer Ventures and Population Health Partners. [read post]
17 Oct 2021, 9:24 pm by Patent Docs
Ltd v Commissioner of Patents [2021] FCA 643, and Merck Sharp & Dohme Corp. v Sandoz Pty Ltd [2021] FCA 947. [read post]
15 Oct 2021, 4:00 am by Martin Kratz
Canadian Institute of Chartered Accountants, 2011 FC 1516, 2011 CarswellNat 5412 at para. 9; Merck & Co. at para. 24). [read post]
11 Oct 2021, 11:10 am by Emily Dai
The event will feature Peter Sands, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria; and Julie Gerberding, executive vice president and chief patient officer at Merck & Co., Inc. [read post]
6 Oct 2021, 1:15 pm by Joseph Allen
The lead story in last weekend’s Wall Street Journal made an exciting announcement: “Merck Covid-19 Pill Cuts Risks of Hospitalizations and Death”: "Merck & Co. and its partner Ridgeback Biotherapeutics LP said their experimental Covid-19 pill helped prevent high-risk people early in the course of the disease in a pivotal study from becoming seriously ill and dying, a big step toward providing the pandemic’s first easy-to-use, at home… [read post]
6 Oct 2021, 1:15 pm by Joseph Allen
The lead story in last weekend’s Wall Street Journal made an exciting announcement: “Merck Covid-19 Pill Cuts Risks of Hospitalizations and Death”: "Merck & Co. and its partner Ridgeback Biotherapeutics LP said their experimental Covid-19 pill helped prevent high-risk people early in the course of the disease in a pivotal study from becoming seriously ill and dying, a big step toward providing the pandemic’s first easy-to-use, at home… [read post]
18 Sep 2021, 2:28 pm by Ilya Somin
The lack of express terms within the statute is significant: even "broad rulemaking power must be exercised within the bounds set by Congress," Merck & Co. v. [read post]
9 Sep 2021, 5:19 am by silverman_admin
The manufacturer, Merck & Co., is accused of rushing the product. [read post]
23 Aug 2021, 3:02 am by Rose Hughes
 The Australian patent office (APO) found that the deadline had been missed for the PTE application (Ono Pharmaceutical Co, Ltd et al [2020] APO 43). [read post]
The two PTE applications This case concerned a patent owned jointly by Ono Pharmaceutical Co and E R Squibb & Sons, LLC (together, Patentees), titled “Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics”. [read post]